Novozymes A/S (OTCMKTS:NVZMY) Sees Significant Decline in Short Interest

Novozymes A/S (OTCMKTS:NVZMY) was the target of a large drop in short interest in the month of January. As of January 15th, there was short interest totaling 27,389 shares, a drop of 67.7% from the December 31st total of 84,786 shares. Based on an average daily trading volume, of 75,516 shares, the days-to-cover ratio is presently 0.4 days. Based on an average daily trading volume, of 75,516 shares, the days-to-cover ratio is presently 0.4 days.

Novozymes A/S Trading Down 0.5%

Shares of OTCMKTS:NVZMY opened at $64.63 on Wednesday. The firm has a market cap of $30.41 billion, a price-to-earnings ratio of 38.24, a PEG ratio of 1.19 and a beta of 1.09. The company has a quick ratio of 1.00, a current ratio of 1.61 and a debt-to-equity ratio of 0.26. Novozymes A/S has a 12 month low of $53.95 and a 12 month high of $75.99. The company’s fifty day simple moving average is $63.18 and its 200 day simple moving average is $63.65.

About Novozymes A/S

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).